Riddhi Anand Bhayani
About Riddhi Anand Bhayani
Data last updated:
Riddhi Anand Bhayani is a Director at Rotek Pharma Technologies Private Limited (since 2021). The company operates in Machinery and Equipment. Rotek Pharma Technologies Private Limited reported revenue of ₹6.79 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Rotek Pharma Technologies Private Limited U29297MH2021PTC355920 | Director | 25 Feb 2021 | 2021 | ₹6.79 Cr (FY 2025) | Active |
Board colleagues of Riddhi Anand Bhayani
| Name | DIN | Company | Designation |
|---|---|---|---|
| Anand Vijay Bhayani | 08980751 | Rotek Pharma Technologies Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Riddhi Anand Bhayani
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Riddhi Anand Bhayani
Riddhi Anand Bhayani currently holds 1 directorship: Rotek Pharma Technologies Private Limited (Director, since 25 Feb 2021, revenue ₹6.79 Cr (FY 2025)).
Riddhi Anand Bhayani was first appointed on 25 Feb 2021 as Director at Rotek Pharma Technologies Private Limited.
The current boards of Riddhi Anand Bhayani's companies include Anand Vijay Bhayani (Rotek Pharma Technologies Private Limited).